Next-generation hospital opens as cancer is set to become leading cause of death (COLUMBUS, Ohio) November 2014 – The newest and one of the largest cancer hospitals in the nation is set to open its doors and usher in a new era in the battle against cancer. By 2030 cancer is expected to overtake heart […]

Robert A. Nagourney, MD, is Medical and Laboratory Director at Rational Therapeutics, Inc., in Long Beach, California, and teaches Pharmacology at the University of California, Irvine School of Medicine. He is board certified in internal medicine, medical oncology, and hematology. During his medical oncology fellowship at Georgetown University, Dr. Nagourney confronted aggressive malignancies for which […]

On November 29, NCI’s Dr. Christine Alewine participated in a Facebook Live event with Lynn Matrisian, Ph.D., Chief Research Officer of the Pancreatic Cancer Action Network. For 30 minutes, they had a vibrant Q&A about the future of pancreatic cancer research and treatment. For more information, please visit http://www.cancer.gov/pancreas

Laxman Mahato was diagnosed with Mouth Cancer. After going to Mumbai and consulting numerous doctors, Laxman Mahato was adviced to visit Brahmananda Narayana Multispeciality Hospital, Jamshedpur, where he received his treatment from Dr. Ashish Kumar, Consultant – Surgical Oncology. #NarayanaHealth #HealthForAll #AllForHealth #NHCares For video consultation with the doctor, log on to https://bit.ly/2z7Y0Bd Visit https://www.narayanahealth.org […]

Matthew Davids, MD, MMSc shares updates from the ASH 2017 Annual Meeting on advances in treating newly-diagnosed and relapsed CLL. New approaches include ibrutinib + FCR for younger, newly-diagnosed patients and a combination of rituximab and venetoclax for relapsed patients. Learn more about Dana-Farber’s Center for Chronic Lymphocytic Leukemia. http://www.dana-farber.org/center-for-chronic-lymphocytic-leukemia/

Nancy Lin, MD, discusses advances in research and treatment for patients with triple-negative metastatic breast cancer. Triple-negative breast cancer, which accounts for about 15% of all breast cancers, are a prime example of how quickly immunotherapy has become a standard part of treatment. Where patients were once treated with chemotherapy regimens, those whose tumors test […]

Rajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier cancer centres and offers the unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries […]

Overview of what to expect during chemotherapy for ovarian cancer.

Dr. Ted Trimble, Director of the National Cancer Institute’s Center for Global Health, shares why he has committed his career to cancer research, and why global research and partnerships are key to accelerating progress against cancer. World Cancer Research Day, September 24, 2017, is a day of recognition for the critical cancer research being done […]

Kenneth Anderson, MD, envisions the future of multiple myeloma treatment with novel therapies, including proteasome inhibitors and immunomodulatory drugs, as well as therapies for smoldering disease. Learn more about the Multiple Myeloma Program at Dana-Farber. https://www.dana-farber.org/multiple-myeloma-program/ View more presentations from the 2017 Multiple Myeloma patient Education Symposium at Dana-Farber Cancer Institute. http://www.dana-farber.org/health-library/videos/multiple-myeloma-patient-symposium-video-presentations/

Slides for this presentation are available on Dana-Farber’s Slideshare page: http://www.slideshare.net/DanaFarber/la-casce-lrf-presentation-mg-edits For more information on Dana-Farber’s Adult Lymphoma Program, visit: http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Hematologic-Oncology-Treatment-Center/Adult-Lymphoma-Program.aspx For more information on clinical trials at Dana-Farber Cancer Institute visit http://www.dana-farber.org/Research/About-Clinical-Trials.aspx Ann LaCasce, MD, MMSc, of Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program, talks about new clinical trials and treatments available for […]

The research done by Dana-Farber Cancer Institute has influenced cancer treatment everywhere. Most pivotal was discovering PD-L1, a protein cancer uses to hide from the immune system. Blocking the PD-L1 pathway enables the immune system to attack cancer. Finding PD-L1 has transformed immunotherapy into a major approach for treating cancer worldwide. From pioneering chemotherapy to […]

http://www.nyp.org/cancer/services/blood-cancer/bone-marrow-transplant NewYork Presbyterian Hospital offers some of the finest Blood Cancer Treatment programs not only in New York, but in the entire world. Our phenomenal team of doctors work cohesively to determine the best treatment for your specific needs, combining both high medical science and professional patient care. For the finest patient care and treatment […]

Jill O’Donnell-Tormey, CEO of the Cancer Research Institute, discusses her organization and the latest advances in cancer immunotherapy.

Oral chemotherapy is a cancer-fighting drug given by mouth in tablet, capsule, or liquid form, and taken at home. Learn what oral chemotherapy is, and how it has the same benefits and risks as chemotherapy given by infusion. Read more about oral chemotherapy at http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Chemotherapy.aspx#Oral_Chemotherapy Transcription: Anti-cancer treatments, such as oral chemotherapy, is a drug […]

Oral chemotherapy is a cancer-fighting drug given by mouth in tablet, capsule, or liquid form. Learn how to manage symptoms and side effects such as fatigue and nausea. Learn more about oral chemotherapy at http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Chemotherapy.aspx#Oral_Chemotherapy Transcription: Taking your pills as directed will help you manage your symptoms. If you have questions about how to take […]

Lisa Diller, MD, discusses some of the fertility side effects that childhood cancer survivors may experience. Specifically, Diller talks about some of the advances in preserving fertility for female survivors. This video is from a webchat on life after childhood cancer treatment, which was held on Feb. 12, 2015. Watch the entire webchat here: https://www.youtube.com/watch?v=VtMxuAmOj-E […]

Comprehensive, Patient-Centred Care in Singapore. The National Cancer Centre Singapore is the largest and comprehensive cancer centre in Singapore, and sees close to 65% of public sector cancer patients. Investing heavily in training, technology, safety and patient care, staff at NCCS get exposure to the very best in oncology. Using a multi-disciplinary and holistic approach […]

Oreofe Odejide, MD, MPH, discusses her work and patient care at the Lymphoma program. She treats patients with non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia (CLL). As lymphoma has over 40 subtypes, Odejide believes that it’s important for patients to understand their diseases, and encourages them to bring their questions to her. Learn more […]

At The Carlo Fidani Regional Cancer Centre we administer many different chemotherapy medications to treat a wide variety of cancers. Chemotherapy drugs are medications that destroy cancer cells. Chemotherapy may involve one drug, or a mixture of two or more drugs, depending on the type of cancer. We are here to work with you to […]

Dr. Michael Rabin, medical director of thoracic oncology, discusses his work in lung cancer treatment and describes Dana-Farber’s intensity of focus on both clinical care and research. Learn more about how Dana-Farber’s physicians treat lung cancer at http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Treatment-Centers-and-Clinical-Services/Thoracic-Cancer-Treatment-Center.aspx.

For people diagnosed with certain types of cancer, hope can be distressingly elusive. That’s especially true with pancreatic cancer, but a new MRI-guided radiation therapy at Miami Cancer Institute has led to extremely encouraging outcomes, according to radiation oncologist Michael Chuong, M.D., [Transcript] Jayne: When I heard the results of my CT scan saying that […]

Andrew Lane, MD, PhD, is a physician in Dana-Farber’s Adult Leukemia program. He treats patients with acute leukemia and blastic plasmacytoid dendritic cell neoplasm (BPDCN). In this video, Dr. Lane shares that working in oncology is very fulfilling for the combination of patient care and cutting-edge research and medicine. Learn more about the Adult Leukemia […]

Dana-Farber/Brigham and Women’s Cancer Center is the first center in New England to offer magnetic resonance imaging or MRI-guided radiation therapy technologies. This video explores what that means for pancreatic cancer patients.

Apollo Hospitals will soon be the first in South Asia to install the Proton Therapy System, PROTEUS PLUS at the Apollo Proton Centre in Chennai.This will be a critical tool to deliver advanced radiation therapy for cancer treatment.​ Proton therapy will provide our team of Oncologists another critical tool in the fight against cancer. Watch […]

Take a video tour of the Johns Hopkins Bayview Medical Center campus’ Sidney Kimmel Comprehensive Cancer Center and its state-of-the-art facilities for cancer treatment, part of the only facility in the state of Maryland to earn a Comprehensive Cancer Center designation from the National Cancer Institute. Meet some of the multidisciplinary team of physicians and […]

A new option for men with metastatic hormone-sensitive prostate cancer that researchers say is superior to the current standard therapy. Christopher Sweeney, MBBS explains. Research presented at #ASCO19 and published in the New England Journal of Medicine. https://www.dana-farber.org/newsroom/news-releases/2019/enzalutamide-improves-survival-for-men-with-metastatic-hormone-sensitive-prostate-cancer/

Dr. Jacob Sands discusses the newest therapies in lung cancer treatment. To learn more about the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, visit https://www.dana-farber.org/thoracic-lung-cancer-treatment-center/

Paul G. Richardson, MD, clinical program leader and director of clinical research, the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute, gives a clinical perspective on the future of multiple myeloma treatments. This presentation was originally given at the Multiple Myeloma Patient Education Symposium on Dec. 13, 2014 […]

The research done by Dana-Farber Cancer Institute has influenced cancer treatment everywhere. Most pivotal was discovering PD-L1, a protein cancer uses to hide from the immune system. Blocking the PD-L1 pathway enables the immune system to attack cancer. Finding PD-L1 has transformed immunotherapy into a major approach for treating cancer worldwide. From pioneering chemotherapy to […]